Procurement Summary
Country: Brazil
Summary: Acquisition of Antineoplastic and Related (Cancer) Drugs with the Objective of Supplying the Federal University Hospitals of the Ebserh Network for the Period 2025-2026.
Deadline: 10 Jul 2025
Other Information
Notice Type: Tender
TOT Ref.No.: 121844062
Document Ref. No.: 90079/2025
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - Acquisition of antineoplastic and related (cancer) drugs with the objective of supplying the federal university hospitals of the EBSERH network for the period 2025-2026.
UASG Code: 155007
Notice from: 06/30/2025 from 08:00 to 17:00
Proposal delivery: a from 06/30/2025 to 08:00
Gosserrelin acetate, dosage 10.80 mg, indication injectable solution
Quantity: 6013
Leupro -owl acetate, concentration 22.5 mg, pharmaceutical form liophile powder for injectable
Quantity: 12175
Nilotinibe, Concentration 200 mg
Quantity: 48035
Pegaspargasis, concentration 750 U/ml, pharmaceutical form injectable solution
Quantity: 1351
Dasatinibe, concentration 100 mg
Quantity: 17622
Fludarabine phosphate, dosage 50 mg, type injectable use
Quantity: 4394
Bleomycin sulfate, concentration 15 u, pharmaceutical form Liophile powder for injectable
Quantity: 9669
Capecitabine, 500 mg dosage
Quantity: 1839734
ANAGRELIDA HYPROID, DOSAGE 0.5 MG
Quantity: 114595
Fluoruracila, dosage 50 mg/ml, use injectable solution
Quantity: 37544
Rituximab, dosage 10mg/ml, indication injectable solution
Quantity: 4752
Leupro -owl acetate, concentration 45 mg, pharmaceutical form Liophile powder for injectable, additional characteristic with application system
Quantity: 5083
Dexrazoxane, 500 mg dosage, injectable pharmaceutical form
Quantity: 462
Hydroxyurea, dosage 500 mg
Quantity: 1772323
Cladribine, concentration 1 mg/ml, pharmaceutical form injectable solution
Amount : 1496
Abiraterone acetate, concentration 250 mg
Quantity: 460980
Bussulfano, concentration 6 mg/ml, pharmaceutical form injectable solution
Quantity: 4369
Gencitabine hydrochloride, dosage 1g, injectable use
Quantity: 35581
FULVESTERTRACT, DOSAGE 50 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION, Additional Characteristics 1 ...
Documents
Tender Notice